NCT06047236View on ClinicalTrials.gov

Immune Biomarker Study for Salivary Gland Carcinoma

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions
Salivary Gland TumorBenign Salivary Gland Tumor
Interventions
OTHER

Sampling

Evaluation of immune characteristics by using patient's stool, saliva and blood samples.

Trial Locations (2)

91054

RECRUITING

Universitätsklinikum Erlangen, HNO, Erlangen

RECRUITING

Universitätsklinikum Erlangen, Strahlenklinik, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER